Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Up 1.00% Nasdaq Up 1.29%
Streaming
Ticker Tape: On

Progenics Pharmaceuticals, Inc. (PGNX)

-NasdaqGS
3.56 Up 0.16(4.71%) Apr 16, 4:00PM EDT
|After Hours : 3.56 0.00 (0.00%) Apr 16, 4:48PM EDT
Get the big picture on all your investments.
Prev Close:3.40
Open:3.44
Bid:2.50 x 100
Ask:3.76 x 2000
1y Target Est:9.50
Beta:1.64
Next Earnings Date:N/A
Day's Range:3.35 - 3.58
52wk Range:3.20 - 7.45
Volume:819,691
Avg Vol (3m):1,453,120
Market Cap:247.69M
P/E (ttm):N/A
EPS (ttm):-0.76
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PGNX

Comparison

Symbol% ChgMkt Cap
PGNXUp 4.71%247.69M
DNDN 0.00%412.52M
NKTRUp 1.52%1.40B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):30.09
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.37
Quarterly EPS Est (Mar-14) :-0.15
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.37

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Progenics Pharmaceuticals, Inc. develops medicines for oncology. The company offers Relistor-subcutaneous injection for the treatment of opioid induced constipation (OIC) in advanced-illness patients receiving palliative care when laxative therapy... View More

Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback